Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Advertisement

Citing this Article

Right click to copy or hit: ctrl+c (cmd+c on mac)

Published on 18.12.19 in Vol 3, No 4 (2019): Oct-Dec

This paper is in the following e-collection/theme issue:

    Original Paper

    Web-Based Module for the Collection of Electronic Patient-Reported Outcomes in People Living With HIV in Nouvelle Aquitaine, France: Usability Evaluation

    1University of Bordeaux, ISPED, Inserm, Bordeaux Population Health Research Center, Team MORPH3EUS, UMR 1219, Bordeaux, France

    2Centre de Recherche et Développement en Informatique Médicale, University of Bordeaux, Bordeaux, France

    3CHU de Bordeaux, COREVIH Nouvelle Aquitaine, Bordeaux, France

    4AIDES Nouvelle Aquitaine, Bordeaux, France

    5CHU de Bordeaux, Service d'information médicale, Pôle de sante publique, Bordeaux, France

    6CHU de Bordeaux, Service de médecine interne et maladie infectieuses, Bordeaux, France

    Corresponding Author:

    Diana Barger, BA, MSc

    University of Bordeaux

    ISPED, Inserm, Bordeaux Population Health Research Center

    Team MORPH3EUS, UMR 1219

    146 rue Leo Saignat CS61292

    Bordeaux, F-33000

    France

    Phone: 33 0557579291

    Email: diana.barger@u-bordeaux.fr


    ABSTRACT

    Background: Patient-reported outcomes (PROs) can be of great value for both research and chronic disease management. We developed a new module of the ANRS CO3 Aquitaine cohort study’s Web-based data capture and visualization solution (APPEGE 2.0) for the collection of electronic PROs among people living with HIV cared for in Nouvelle Aquitaine, France.

    Objective: This study aimed to evaluate the usability of 2 successively developed prototypes of ARPEGE 2.0’s electronic PROs module before launching a pilot study, owing to the novelty of the proposed data collection method for our setting and specific characteristics of the target population.

    Methods: A total of 2 sequential rounds of empirical, task-based usability evaluations were conducted, involving 8 research staff and then 7 people living with HIV. Evaluators provided written feedback during round 1 and oral feedback during round 2. Evaluators who completed the full set of tasks responded to the System Usability Scale (SUS). We assessed changes in SUS scores between rounds and concluded usability testing when SUS scores reached a ceiling effect, defining good usability a priori as a usability score of 70.

    Results: Insights were generated regarding the visibility of system status and the match between the system and the real world that improved the module’s usability. Research staff evaluators reported mean SUS scores of 65 (SD 18.87) and patient evaluators reported mean SUS scores of 85 (SD 5.4; P=.032).

    Conclusions: Software modifications, informed by successive rounds of usability testing, resulted in sufficient gains in usability to undertake piloting. Insights generated during evaluations prompted us to find the appropriate balance between optimal security and ease of use.

    Trial Registration: ClinicalTrials.gov NCT03296202; https://clinicaltrials.gov/ct2/show/NCT03296202

    International Registered Report Identifier (IRRID): RR2-10.2196/10.2196/resprot.9439

    JMIR Form Res 2019;3(4):e15013

    doi:10.2196/15013

    KEYWORDS



    Introduction

    HIV, once fatal, is now a manageable chronic illness [1]. In Western Europe, the majority of individuals who received a diagnosis of HIV are in care and on potent antiretroviral therapy, which prevents serious diseases both related and unrelated to AIDS [2]. The improved prognosis and the increased life expectancy of people living with HIV (PLWH) makes preserving health and ensuring good quality of life the cornerstone of their care [3-5]. One strategy to help providers respond to PLWH’s evolving needs and improve the quality and efficiency of their overall care is collecting and using patient-reported outcomes (PROs) [6].

    PROs or “any report of the status of the patient’s health condition that comes directly from the patient, without interpretation of the patient’s response by a clinician or anyone else” [7] have been used extensively in clinical research [6]. PROs can be used at the population level for research and to improve the quality of care or at the individual level to support clinical decision making [8]. Their use may allow for more accurate symptom detection, better patient-provider communication, and improved outcomes [9]. Logistical, technical, and ideological barriers have nevertheless limited their use in routine care [10]. The adoption of electronic medical records coupled with the adaptation of paper questionnaires to computerized and internet-based formats may help overcome these barriers [10,11].

    With evidence from the United States suggesting that the collection of PROs by using touchscreen-based information technology was both feasible and of value for both research and clinical HIV care [12-14], a prototype of an electronic PRO module linked to the ANRS CO3 Aquitaine cohort’s data capture and visualization system (ARPEGE 2.0) was developed in 2017 [15]. As the overall usefulness of interactive health care applications or their usability is likely to affect their acceptability and adoption, usability evaluations of 2 successively developed prototypes of the ARPEGE 2.0 solution were conducted in preparation for a pilot study [15].


    Methods

    This formative research study took place in Bordeaux, France, at the Inserm UMR 1219-Bordeaux Population Health Research Centre and the St André Bordeaux University Hospital. It was designed as part of the ANRS CO3 Aquitaine study, an open, prospective hospital-based cohort of PLWH in care in 13 clinics in southwestern France. A local institutional review board approved the study’s protocol (Comité de Protection de Personnes Sud-Ouest et Outre-Mer III) on September 18, 2017.

    Description of the Electronic Patient-Reported Outcome Module Powered by ARPEGE 2.0

    ARPEGE 1.0 is a proprietary, secure, electronic case report form developed in Microsoft ASP.NET (WebForm). Data are stored within a Microsoft SQL Server 2014–based data management system. The ANRS CO3 Aquitaine cohort relies on ARPEGE 1.0 for data capture. Clinical data, extracted from both medical records and laboratory data, derived from the hospital’s laboratory information management systems, have been collected systematically since 1987 and electronically via ARPEGE 1.0 since 2013 with the support of Clinical Research Associates. ARPEGE 2.0 is a generic Web-based data capture and visualization system also developed in Microsoft ASP.NET (WebForm). ARPEGE 2.0 has enabled the creation of the module for the collection of electronic PROs in routine care for observational research and, ultimately, clinical care.

    The content of ARPEGE 2.0’s initial electronic PRO module is based on current treatment guidelines for people being treated for HIV and associated comorbidities [16]. Prototyping was carried out over 2017 with the support and regular feedback from a working group comprising research staff, local stakeholders, and end users (clinicians and patient representatives). The questionnaires were evaluated individually according to their psychometric properties, administration method, and length. The following areas are covered by the electronic PRO module: socioeconomic status and individual social and material deprivation [17], multidimensional quality of life (WHOQOL-HIV BREF) [18], treatment burden (Treatment Burden Questionnaire) [19], physical activity (the Short Version of the International Physical Activity Questionnaire), alcohol use and screening for at-risk drinking behavior (Alcohol Use Disorders Identification Test Consumption, Fast Alcohol Consumption Evaluation) [20], tobacco and nicotine use and screening for tobacco dependency (Fagerström), cannabis (Cannabis Abuse Screening Test) and drug use, and, finally, depression (Patient Health Questionnaire) [21].

    Conditional branching was used where appropriate. The module also allows patients to report any other treatment-related issues in a free text field. Where applicable, the International Society for Pharmacoeconomics and Outcomes Research ePRO Task Force’s recommendations on adapting paper-based instruments were followed, ensuring that data produced are equivalent or superior to those generated from paper-based administration methods [22].

    Recruitment

    Nielsen’s recommendations that favor conducting several iterative studies, each with a small number of participants, were adopted [23]. In round 1 (May 2018), evaluators were employees of the Inserm UMR 1219 Bordeaux Population Health Research Center or affiliated with the project, referred to herein as research staff. In round 2 (June 2018), a convenience sample of PLWH being cared for at the St André Bordeaux University Hospital was identified by clinical staff either before or during their routine visit.

    Procedure

    The evaluation procedure differed between round 1 and round 2. However, for both rounds, oral consent was obtained. It was then explained that each study participant (evaluator) would be provided with a unique identifier, which would allow him/her to create a personal account and access the questionnaires. Evaluators were shown the study-specific brochure where the number would be written on a detachable coupon (Multimedia Appendix 1). They were asked to complete 5 tasks: (1) navigate between pages on the publicly available website and locate key information, (2) create a user account, (3) confirm their account, (4) initiate the electronic PRO assessment, and (5) complete the electronic PRO assessment. Whether or not each task was completed with ease, assistance or not was monitored, and a score of 2 to 0 was attributed (2=the task was completed with ease and 0=it was not completed). The highest possible score was therefore 10, and the lowest score was 0. Neither round 1 nor round 2 evaluators were compensated.

    In round 1, research staff were provided with instructions detailing the background of the study and how it would be implemented in a clinical setting. Evaluators were given a link to a staging version of the electronic PRO module. They were asked to complete the previously described tasks. They then responded to an Web-based questionnaire that included the System Usability Scale (SUS), a widely used robust tool for measuring usability. It consists of 10 items with 5 response options, from strongly agree to strongly disagree [24,25]. Evaluators provided written feedback in an open text field and by email.

    In round 2, patients participated in one-on-one testing sessions, lasting between 1 and 2 hours, with a researcher in a dedicated, private space at the hospital (June 2018). The researcher based each session on a standardized qualitative interview guide. A personal computer (Mac Book Air) with access to the staging site was provided to complete the study tasks. Patient evaluators were also allowed to complete the questionnaire on their personal smartphones, matching how the electronic PRO module might be accessed in routine care. Evaluators were instructed to use the think aloud method, in which users are asked to verbalize all thoughts as they interact with the system while carrying out tasks. Subsequently, those who completed all tasks responded orally to the SUS and provided open-ended feedback [24]. All sessions were audio recorded, and field notes were taken.

    Analysis

    Task completion and SUS scores were calculated for each evaluator, and means and standard deviations were calculated for each round. We performed a t test assuming unequal variance to determine if each round of testing produced significant difference in the mean SUS scores. A priori, we defined success in usability when the SUS score reached a ceiling effect, with a minimum score of 70—generally accepted as a cut-off for good usability [26].

    Qualitative analysis included review of written feedback, audio recording–enhanced field notes, and responses to open-ended questions. We performed thematic content analysis on written feedback and audio recording–enhanced field notes, abstracting and compiling emerging themes from each round of testing. These are reported according to Nielsen’s usability heuristic categories [27].


    Results

    Overview

    Table 1 presents evaluators’ characteristics and mean task completion scores for rounds 1 and 2. The majority of round 1 evaluators were women (7/8). They reported using computers either regularly (5/8) or often (3/8). In all, 5 out of 7 round 2 evaluators were men. A total of 3 reported using a computer regularly, 3 often, and 1 never. Overall, mean task completion scores were 7.8 (out of 10) in round 1 and 7.1 in round 2. In round 1, 7 evaluators completed all tasks compared with 4 out of 7 in round 2. Task completion was hampered owing to 2 evaluators being locked out of their accounts and 1 evaluator being unable to complete tasks owing to poor eyesight. This evaluator was attributed 0 on all tasks.

    The usability insights uncovered during the 2 rounds of usability evaluations together with the solutions adopted are presented in Table 2.

    Table 1. Evaluator characteristics and task scores.
    View this table
    Table 2. Usability insights per round and solution adopted according to Nielsen’s usability heuristics.
    View this table

    What Worked

    The first task involved navigating the external website that patients would access from home, unassisted, to create their account. Users found the information provided on the external website quickly and found its structure clear. All users quickly understood how the attributed unique identifier would be used to create their personal account. Once users had created their account, efforts to guide him/her through electronic PROs by having each questionnaire open one after the other appeared to work well. The use of stoplight-style color coding and a progress bar allowed users to see if they had missed a question and helped them recognize, diagnose, and recover from errors seamlessly. The order of the PROs was received positively by users and therefore remained unchanged between prototype versions.

    What Did Not Work

    The account creation task was the most challenging for users. One of the issues identified was the complexity of the password requirements. The password had to be entered twice and contain at least 8 alphanumeric characters, including 2 special characters and a capital letter (Figure 1). Many evaluators, both research staff and patients, attempted this step more than once. We clarified the password requirements and ensured that error messages were informative regarding the system status, and we made it possible to visualize the password after round 1 (Figure 2). As errors still occurred, we added additional error prevention features. The password is validated as the user types as opposed to the user receiving an error message upon clicking register (Multimedia Appendix 2).

    Figure 1. Initial log-in page (round 1).
    View this figure
    Figure 2. Revised log-in page (round 2).
    View this figure

    A login problem, also detected during the second round of usability testing, was being locked out of one’s account accidentally. This issue arose from a security measure included in the electronic PRO module’s design. Users were logged out automatically after a period of 20 min of inactivity. If users accidently left the page without logging out of their accounts, they could no longer log back in owing to the Bordeaux University servers’ restrictions. If the user attempted to return to their account, they received an error message indicating that they were already connected. This issue could not be resolved without completely relaxing the automatic logout timeframe (shortening it). We therefore modified the error message indicating that the user could access their account again in 20 min.

    System Usability Scale Scores

    In round 1, experts reported mean SUS scores of 65 (SD 18.87), and patients, in round 2, reported mean SUS scores of 85 (SD 5.4) (P=.032).


    Discussion

    Principal Findings

    Iterative usability evaluations of 2 successively developed prototypes allowed us to see how easy our electronic PRO module was to use and identify when and where users encountered problems or experienced confusion. We were able to improve the module’s usability markedly, specifically the visibility of system status and the match between the system and the real world, and take into account the specific needs of our patient population (their level of computer literacy and age) and the specificities of our clinical setting. Finally, we were pushed to find the appropriate balance between optimal security and ease of use.

    Unlike PRO collection methods employed in clinics in the United States [12-14], where patients complete an electronic PRO assessment by using touchscreen information technology with the assistance of a research assistant/administrator at clinics, we aimed to design a Web-based Bring Your Own Device solution. We therefore assumed that the majority of users would have access to a smartphone or personal computer with a reliable internet connection. The proposed solution, developed in-house, had to work well enough to allow a group of users, with varying levels of computer familiarity, to use it with little to no assistance.

    Strengths and Limitations

    Some caveats should be considered in the interpretation of our results. We conducted the first round of usability testing in a sample of research staff who may not fully represent end users. This strategy, recognized as an easy way of catching obvious usability issues, resulted in high-quality, detail-oriented, and exhaustive feedback, allowing for a number of basic usability problems to be resolved before evaluations with patients. Most evaluators were comfortable using computers and the internet. They may not fully reflect the diversity of the cohort of PLWH in the region. More purposeful sampling of evaluators with lower computer literacy may have resulted in the detection of additional usability insights.

    In round 2, we used the think aloud method. This method has been known to slow the thought process and increase mindfulness, which might prevent errors that might have normally occurred [28]. However, when evaluators are asked to perform simple tasks, the method has been shown to have no effect on user performance [29]. We opted for this method as the tasks were not considered complex.

    Conclusions

    Nevertheless, software modifications, informed by successive rounds of usability testing, resulted in sufficient gains in usability to undertake piloting.

    Acknowledgments

    Alain Volny-Anne (European AIDS Treatment Group) and Eugenie Destandau provided valuable feedback on the design and content and the QuAliV website and electronic PRO module. The authors would like to thank all of the evaluators, both research staff and patients, who contributed to this study. They thank the scientific committee, clinical sites and their investigators, and clinical research associates, further cited, who have been involved in the successful implementation of the subsequent phase of the study.

    ANRS CO3 Aquitaine Cohort—Scientific Committee: F Bonnet (Principal Investigator), L Wittkop (Methodologist); C Cazanave, V Gaborieau, M Hessamfar, E Lazaro, G Le Moal, D Malvy, P Mercié, D Neau, MO Vareil, I Pellegrin, P Blanco, ME Lafon, P Bellecave, S Bouchet, D Breilh, D Lacoste, S Lawson-Ayayi, A Gimbert, S Desjardin, L Lacaze-Buzy, V Petrov-Sanchez, L Marchand, A Perrier, F Le Marec, and O Leleux.

    Clinical Sites and Investigators: Hôpital Saint André, CHU de Bordeaux, Médecine Interne et Maladies Infectieuses, (F Bonnet, N Bernard, D Dondia, P Duffau, I Faure, M Hessamfar, D Lacoste, P Mercié, P Morlat, F Paccalin, MC Pertusa, MA Vandenhende, E Riebero, and C Rivoisy); Hôpital Pellegrin, CHU de Bordeaux, Maladies Infectieuses et Tropicales, (C Cazanave, FA Dauchy, A Desclaux, M Dupon, H Dutronc, D Neau, D Malvy, A Ochoa, T Pistone, MC Receveur, G Wirth); Hôpital Haut-Lévêque, CHU de Bordeaux, Médecine Interne et Maladies Infectieuses, (C Greib, E Lazaro, JL Pellegrin, JF Viallard); Hôpital d’Agen, Médecine Interne (Y Imbert, M Thierry-Mieg, P Rispal); Hôpital de Libourne, Médecine Interne (O Caubet, H Ferrand, S Tchamgoué); Hôpital de Bayonne, Maladies Infectieuses (S Farbos, MO Vareil, H Wille); Hôpital de Dax, Médecine Interne et Maladies Infectieuses, (K Andre, L Caunegre, Y Gerard, F Osorio-Perez); Hôpital Saint-Cyr/Villeneuve-sur-Lot, Maladies Infectieuses, (I Chossat) ; Hôpital de Mont de Marsan, Médecine Interne et Maladies Infectieuses, (G Iles, Y Gerard, M Labasse-Depis, F Lacassin); Hôpital d’Arcachon, Médecine Interne, (A Barret, C Courtault) ; Hôpital de Périgueux, Médecine Interne et Maladies Infectieuses, (N Berthol, B Cougoul, P Lataste, J Marie, N Rouanes); Hôpital de Pau, Médecine Interne et Maladies Infectieuses, (G Dumondin, V Gaborieau); Hôpital d’Orthez, Médecine Interne, (Y Gerard).

    Clinical Research Associates: S Delveaux, B Uwamaliya, K Zara, A Pougetoux, F Diarra, C Hanapier, MJ Blaizeau, M Decoin, E Lenaud, and S Lawson-Ayayi.

    Project Team: A Perrier (Data Manager), F Le Marec (Statistician), and O Leleux (Project Leader).

    The Aquitaine ANRS Cohort is sponsored by the Bordeaux University Hospital and funded by the ANRS (France REcherche Nord&Sud Sida-hiv Hépatites) and the Bordeaux University Hospital. The cohort is coordinated from within the Inserm UMR 1219—Bordeaux Population Health Research Centre. Seed funding was granted by the ANRS in 2017 via the CSS-5 call to develop the electronic PRO module. Diana Barger was awarded a 36-month young researcher grant from Sidaction to design and conduct a study on quality of life in PLWH within the ANRS CO3 Aquitaine cohort as part of her doctoral research.

    Conflicts of Interest

    DB has received a speaking fee from Gilead. FB declares to have received reimbursement for attending a symposium from ViiV Healthcare, Gilead, Bristol-Myers Squib, Merck and Janssen, speaking fee and consultancy fee from ViiV Healthcare, Gilead, Bristol-Myers Squib, Merck and Janssen, and funds for research from Gilead and ViiV Healthcare. The other authors do not have any conflict of interest to declare.

    Multimedia Appendix 1

    Patient brochure with unique identifier.

    PNG File , 478 KB

    Multimedia Appendix 2

    Login page with password verification.

    PNG File , 234 KB

    References

    1. Deeks SG, Lewin SR, Havlir DV. The end of AIDS: HIV infection as a chronic disease. Lancet 2013 Nov 2;382(9903):1525-1533 [FREE Full text] [CrossRef] [Medline]
    2. INSIGHT START Study Group, Lundgren JD, Babiker AG, Gordin F, Emery S, Grund B, et al. Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med 2015 Aug 27;373(9):795-807 [FREE Full text] [CrossRef] [Medline]
    3. Rasmussen LD, Obel N. How do we preserve health among adults living with HIV? Lancet HIV 2019 Feb;6(2):e69-e70. [CrossRef] [Medline]
    4. Antiretroviral Therapy Cohort Collaboration. Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies. Lancet HIV 2017 Aug;4(8):e349-e356 [FREE Full text] [CrossRef] [Medline]
    5. Lazarus JV, Safreed-Harmon K, Barton SE, Costagliola D, Dedes N, Valero J, et al. Beyond viral suppression of HIV - the new quality of life frontier. BMC Med 2016 Jun 22;14(1):94 [FREE Full text] [CrossRef] [Medline]
    6. Engler K, Lessard D, Lebouché B. A review of HIV-specific patient-reported outcome measures. Patient 2017 Apr;10(2):187-202. [CrossRef] [Medline]
    7. Food and Drug Administration. 2009 Oct. Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims   URL: https:/​/www.​fda.gov/​regulatory-information/​search-fda-guidance-documents/​patient-reported-outcome-measures-use-medical-product-development-support-labeling-claims [accessed 2019-11-12]
    8. Snyder CF, Aaronson NK, Choucair AK, Elliott TE, Greenhalgh J, Halyard MY, et al. Implementing patient-reported outcomes assessment in clinical practice: a review of the options and considerations. Qual Life Res 2012 Oct;21(8):1305-1314. [CrossRef] [Medline]
    9. Greenhalgh J, Long AF, Flynn R. The use of patient reported outcome measures in routine clinical practice: lack of impact or lack of theory? Soc Sci Med 2005 Feb;60(4):833-843. [CrossRef] [Medline]
    10. Jones JB, Snyder CF, Wu AW. Issues in the design of internet-based systems for collecting patient-reported outcomes. Qual Life Res 2007 Oct;16(8):1407-1417. [CrossRef] [Medline]
    11. Gensheimer SG, Wu AW, Snyder CF, PRO-EHR Users’ Guide Steering Group, PRO-EHR Users’ Guide Working Group. Oh, the places we'll go: patient-reported outcomes and electronic health records. Patient 2018 Dec;11(6):591-598. [CrossRef] [Medline]
    12. Crane HM, Lober W, Webster E, Harrington RD, Crane PK, Davis TE, et al. Routine collection of patient-reported outcomes in an HIV clinic setting: the first 100 patients. Curr HIV Res 2007 Jan;5(1):109-118. [CrossRef] [Medline]
    13. Kozak MS, Mugavero MJ, Ye J, Aban I, Lawrence ST, Nevin CR, et al. Patient reported outcomes in routine care: advancing data capture for HIV cohort research. Clin Infect Dis 2012 Jan 1;54(1):141-147 [FREE Full text] [CrossRef] [Medline]
    14. Schumacher JE, McCullumsmith C, Mugavero MJ, Ingle-Pang PE, Raper JL, Willig JH, et al. Routine depression screening in an HIV clinic cohort identifies patients with complex psychiatric co-morbidities who show significant response to treatment. AIDS Behav 2013 Oct;17(8):2781-2791 [FREE Full text] [CrossRef] [Medline]
    15. Barger D, Leleux O, Conte V, Sapparrart V, Gapillout M, Crespel I, et al. Integrating electronic patient-reported outcome measures into routine HIV care and the ANRS CO3 Aquitaine Cohort's Data Capture and Visualization System (QuAliV): protocol for a formative research study. JMIR Res Protoc 2018 Jun 7;7(6):e147 [FREE Full text] [CrossRef] [Medline]
    16. Ministry of Solidarity and Health. 2013. Medical management of people living with HIV, recommendations of the expert group, 2013 report   URL: http://solidarites-sante.gouv.fr/IMG/pdf/Rapport_Morlat_2013_Mise_en_ligne.pdf [accessed 2017-11-16] [WebCite Cache]
    17. Labbe E, Blanquet M, Gerbaud L, Poirier G, Sass C, Vendittelli F, et al. A new reliable index to measure individual deprivation: the EPICES score. Eur J Public Health 2015 Aug;25(4):604-609. [CrossRef] [Medline]
    18. O'Connell KA, Skevington SM. An international quality of life instrument to assess wellbeing in adults who are HIV-positive: a short form of the WHOQOL-HIV (31 items). AIDS Behav 2012 Feb;16(2):452-460. [CrossRef] [Medline]
    19. Tran V, Montori VM, Eton DT, Baruch D, Falissard B, Ravaud P. Development and description of measurement properties of an instrument to assess treatment burden among patients with multiple chronic conditions. BMC Med 2012 Jul 4;10:68 [FREE Full text] [CrossRef] [Medline]
    20. Dawson DA, Grant BF, Stinson FS, Zhou Y. Effectiveness of the derived Alcohol Use Disorders Identification Test (AUDIT-C) in screening for alcohol use disorders and risk drinking in the US general population. Alcohol Clin Exp Res 2005 May;29(5):844-854. [CrossRef] [Medline]
    21. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001 Sep;16(9):606-613 [FREE Full text] [CrossRef] [Medline]
    22. Coons SJ, Gwaltney CJ, Hays RD, Lundy JJ, Sloan JA, Revicki DA, ISPOR ePRO Task Force. Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome (PRO) measures: ISPOR ePRO Good Research Practices Task Force report. Value Health 2009 Jun;12(4):419-429 [FREE Full text] [CrossRef] [Medline]
    23. Nielsen J, Landauer TK. A Mathematical Model of the Finding of Usability Problems. In: Proceedings of the INTERACT '93 and CHI '93 Conference on Human Factors in Computing Systems. 1993 Presented at: CHI'93; April 24-29, 1993; Amsterdam, The Netherlands p. 206-213.
    24. Brooke J. Hell - Jens Oliver Meiert. 1996. SUS - A Quick and Dirty Usability Scale   URL: https://hell.meiert.org/core/pdf/sus.pdf [accessed 2019-11-12]
    25. Bangor A, Kortum PT, Miller JT. An empirical evaluation of the system usability scale. Int J Human-Comput Interact 2008;24(6):574-594. [CrossRef]
    26. Sauro J. User Experience Magazine. 2011 Aug. SUStisfied? Little-Known System Usability Scale Facts   URL: https://uxpamagazine.org/sustified/ [accessed 2019-06-15]
    27. Nielsen J. Nielsen Norman Group: UX Training, Consulting, & Research. 2012 Jan 3. Usability 101: Introduction to Usability   URL: https://www.nngroup.com/articles/usability-101-introduction-to-usability/ [accessed 2019-04-12]
    28. Dumas JS, Redish JC. A Practical Guide To Usability Testing. Bristol: Intellect Ltd; 1994.
    29. Ericsson AK, Herbert SA. Protocol Analysis: Verbal Reports As Data. Boston: The Mit Press; 1993.


    Abbreviations

    PLWH: people living with HIV
    PRO: patient-reported outcome
    SUS: System Usability Scale


    Edited by G Eysenbach; submitted 12.06.19; peer-reviewed by K Engler, C Johnson, C Chen; comments to author 19.07.19; revised version received 07.08.19; accepted 07.09.19; published 18.12.19

    ©Diana Barger, Olivier Leleux, Valérie Conte, Vincent Sapparrart, Marie Gapillout, Isabelle Crespel, Marie Erramouspe, Sandrine Delveaux, Linda Wittkop, François Dabis, Fabrice Bonnet. Originally published in JMIR Formative Research (http://formative.jmir.org), 18.12.2019.

    This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Formative Research, is properly cited. The complete bibliographic information, a link to the original publication on http://formative.jmir.org, as well as this copyright and license information must be included.